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Abstract
Spontaneous or chemically induced germline mutations, which lead to Mendelian phenotypes, are powerful tools to
discover new genes and their functions. Here, we report an autosomal recessive mutation that occurred spontaneously in a
Brown-Norway (BN) rat colony and was identified as causing marked T cell lymphopenia. This mutation was stabilized in a
new rat strain, named BN
m for ‘‘BN mutated.’’ In BN
m rats, we found that the T cell lymphopenia originated in the thymus,
was intrinsic to CD4 T lymphocytes, and was associated with the development of an inflammatory bowel disease.
Furthermore, we demonstrate that the suppressive activity of both peripheral and thymic CD4
+ CD25
bright regulatory T cells
(Treg) is defective in BN
m rats. Complementation of mutant animals with BN Treg decreases disease incidence and severity,
thus suggesting that the impaired Treg function is involved in the development of inflammatory bowel disease in BN
m rats.
Moreover, the cytokine profile of effector CD4 T cells is skewed toward Th2 and Th17 phenotypes in BN
m rats. Linkage
analysis and genetic dissection of the CD4 T cell lymphopenia in rats issued from BN
m6DA crosses allowed the localization
of the mutation on chromosome 1, within a 1.5 megabase interval. Gene expression and sequencing studies identified a
frameshift mutation caused by a four-nucleotide insertion in the Themis gene, leading to its disruption. This result is the first
to link Themis to the suppressive function of Treg and to suggest that, in Themis-deficient animals, defect of this function is
involved in intestinal inflammation. Thus, this study highlights the importance of Themis as a new target gene that could
participate in the pathogenesis of immune diseases characterized by chronic inflammation resulting from a defect in the
Treg compartment.
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Introduction
Immune-mediated diseases are multifactorial disorders, result-
ing from complex interactions between multiple genes and the
environment [1]. Deciphering the genetic bases of these diseases is
a difficult task. Genetic association studies in human have recently
identified numerous risk loci associated with susceptibility to
immune-mediated diseases [2–4], but few causal genes have been
unambiguously identified so far as being directly involved in a
particular disease. In addition, identifying the exact mechanisms of
action of these genes often remains a significant barrier to progress.
Mouse and rat models of human diseases are simplified systems in
which environmental factors are under control and genetic
heterogeneity is eliminated. They represent invaluable tools to
identify new genes involved in human diseases. They also offer
efficient systems for studying in-depth mechanisms of gene action.
Two different and complementary approaches can be followed to
investigate the function of a single gene and the pathological
consequences of its dysfunction. First, the gene-driven approach can
be used to investigate the consequences of the modification or
invalidation of a known gene, using genetically modified animals
such as knock-out and knock-in models. Second, the phenotype-
driven approach aims at elucidating the gene and mechanisms
involved in a given phenotype, identified either after a spontaneous
mutation occurring in an animal colony [5], or generated by ran-
dom mutagenesis with a mutagen such as N-ethyl-N-nitrosourea
(ENU) [6].
Here, we report the identification of an autosomal recessive
mutation responsible for T cell lymphopenia, which arose spontane-
ously in our Brown-Norway (BN) rat colony. This mutation was
PLoS Genetics | www.plosgenetics.org 1 January 2012 | Volume 8 | Issue 1 | e1002461associated with a high incidence of inflammatory bowel disease (IBD),
skewed cytokine profile of effector T cells towards Th2/Th17 and
inefficient natural regulatory CD4 T lymphocytes (Treg). We thus
sought to identify the mutated gene by positional cloning, and found a
disruption of the Themis gene. Our study provides the first evidence for
a role of Themis in CD4 T cell functions and in digestive tract
homeostasis.
Results
BN
m rats exhibit a defect in thymic CD4 T cell
development
In the course of our ongoing studies on rat immunogenetics, we
serendipitously observed that, within a litter of BN rats, ,1/4 of
the offspring showed a marked reduction of the proportion of T
cells in the peripheral blood. Intercrosses rapidly led us to
conclude that a spontaneous autosomal recessive mutation was
responsible for this lymphopenia (Figure 1A). This mutation,
which leads to an unambiguous and fully penetrant phenotype,
was isolated and stabilized to homozygocity in a new rat strain
named BN
m, for ‘‘BN mutated’’. Phenotypic analysis of cells from
secondary lymphoid organs revealed that the proportion
(Figure 1B) and absolute numbers (Figure 1C) of CD4 T cells
were markedly reduced in spleen (Figure 1B–1C) and lymph nodes
(LN) of BN
m rats (Figure S1). Numbers of CD8 T cells, B cells,
macrophages, cd T cells and NK cells were not significantly
affected (Figure 1C and data not shown). In the thymus, while no
decrease was observed in double negative (DN), double positive
(DP), or CD8 single positive (SP) thymocytes, the proportion
(Figure 1D) and absolute numbers (Figure 1E) of CD4 SP cells of
BN
m rats were greatly reduced, showing that the CD4 T cell
lymphopenia originates in the thymus. Results from bone marrow
chimeras demonstrated that this CD4 T cell deficiency was
intrinsic to hematopoietic cells and did not depend on the ability of
thymic epithelial cells to support CD4 T cell differentiation
(Figure 1F, Figure S2). Finally, by using intrathymic transfer of
purified T cell precursors (DN thymocytes) from BN or BN
m rats
into (LEW6BN) F1 rats, we documented that this defect was
intrinsic to T cells rather than being dependent on the thymic
environment (Figure 1G).
BN
m rats develop inflammatory bowel disease
We looked for the presence of autoantibodies using sera from 12
week-old BN
m (n=18) and BN rats (n=5). We found that sera
from BN
m rats contained autoantibodies that recognize gut (66%),
kidney (50%), liver (50%) and lung (55%) tissues (Figure S3A). The
antibodies recognized wall component(s) of arterioles and venules
(liver, lung and kidney) and muscular layers in the intestine. In the
kidney, a weak labeling was also observed in the glomerular
mesangium. The nature of the labeled histological structures
suggests that the autoantibodies are mainly raised against smooth
muscles. These autoantibodies were undetectable in BN rats. We
then examined organs from BN
m and age-matched control BN
rats and showed the presence of tissue inflammation affecting the
gut of BN
m rats. Indeed, macroscopic lesions were often observed
in the intestinal tract from both male and female BN
m rats
(Figure 2A). Shortening of the intestine (Figure 2B) and thickening
of the intestinal wall (Figure 2C) were associated with inflamma-
tory features including oedema, erythema, and increased mucus
secretion. The earliest intestinal lesions were detected in 7-week-
old animals, and by 12 weeks of age, disease prevalence reached
50 percent (Figure S3B). Histological analyses revealed slight to
severe multifocal infiltration of the intestine wall, involving
preferentially the muscular layers and the submucosa (Figure 2D,
Figure S3C), whereas the intestinal mucosa did not display any
infiltration or ulcerative lesions. Lesions were scattered all along
the intestine (Figure 2D). The infiltration was predominantly
composed of polymorphonuclear cells and macrophages (CD68
+)
with few T cells (CD3
+) and no B cells (B220
+) (Figure 2E). In
addition, granulomas composed mainly of macrophages and
polymorphonuclear leucocytes were often observed (Figure 2D–
2E). The infiltration of polymorphonuclear cells was confirmed by
a significant increase in myeloperoxidase (MPO) activity in the
duodenum, jejunum, ileum and colon samples from BN
m rats
(Figure 2F). These inflammatory features were associated with
increased levels of IL-6, TNF, IL-1b, IL-13, CCL2 and CCL3 in
the intestinal tissues (Figure 2G). Transcript levels for IL-2 and IL-
17 were also highly increased in the inflamed tissues from BN
m
rats (Figure 2H). To assess whether the CD4 T cell lymphopenia
observed in BN
m rats is sufficient to explain IBD development,
wild type BN rats were thymectomized and treated with anti-CD4
depleting mAb. Using this protocol, we were able to induce a CD4
lymphopenia similar to that observed in BN
m rats, in terms of
number and phenotype of CD4 T cells (data not shown).
However, lymphopenic BN rats did not develop clinical or
histological manifestation of IBD (data not shown). These results
suggest that the mutated gene is responsible for IBD occurrence by
other mechanisms than the simple induction of CD4 lymphopenia.
Thus, BN
m rats harbor a mutation that predisposes to inflamma-
tory lesions of the whole intestine that share pathological features
with human IBD.
BN
m rats exhibit spontaneous CD4 T cell activation and
skewed cytokine production
As abnormal T cell activation is often associated with
inflammatory diseases, we assessed the phenotype and functions
of peripheral T cells in BN
m rats. We observed an increased
proportion of activated and memory-like CD4 T cells (OX40
high
CD62L
low CD45RC
low CD25
high) in spleen (Figure 3A) and
mesenteric lymph nodes (mLN) (Figure S4A). Moreover, CD4 T
cells purified from BN
m spleen (Figure 3B) and mLN (Figure S4B)
exhibited an increased capacity to proliferate under low co-
Author Summary
Deciphering the genetic basis of human diseases and
understanding the function of mammalian genes are
among the main challenges for today’s geneticists. In this
regard, rodent models represent invaluable tools to
identify new genes and to study the mechanisms of
action of genes implicated in human diseases. Here, we
identified a spontaneous mutation responsible for a
reduction of blood CD4 T lymphocyte counts in a rat
strain. The mutant rats showed a high incidence of
inflammatory bowel disease, which was associated with
skewed cytokine secretion by effector CD4 T cells towards
Th2 and Th17 and with impairment of the suppressive
activity of the regulatory CD4 T cells (Treg). The
contribution of Treg was further evidenced by experiments
showing that transfer of Treg from normal BN rats to
mutant animals prevented the occurrence of bowel
lesions. By genetic mapping the lymphopenia, we
identified a disruption of the Themis gene. This result is
the first to link Themis to the suppressive function of Treg
and to suggest that, in Themis-deficient animals, a defect
of this function predisposes to intestinal inflammation.
Thus, this new rat model highlights key roles of Themis
both in regulating the immune system and in maintaining
intestinal homeostasis.
Themis in Immune and Intestinal Homeostasis
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from BN and BN
m rats proliferated equally well, but BN
m CD4 T
cells produced higher amounts of IL-4, IL-5, IL-13, IL-10, IL-17
and lower amounts of IFN-c (Figure 3B and Figure S4B). To assess
whether these phenotypes were the consequence of the higher
proportion of activated CD4 T cells in BN
m rats, similar
experiments were performed with purified naive CD62L
+ CD4 T
cells. Under the same conditions of stimulation, although naive BN
and BN
m CD4 T cells proliferated equally well, they still differed in
their cytokine production, particularly for IL-10, IL-17 and IFN-c
(Figure 3C). Finally, we analyzed the contribution of CD4 T cells to
IBD development in BN
m rats and found that their depletion
reduced both IBD incidence and severity (Figure S4C), indicating
that CD4 T cells are involved in IBD development. Collectively,
these data demonstrate that the mutation present in BN
m rats
influences CD4 T cell activation and differentiation into Th1/Th2/
Th17 subsets and that CD4 T cells contribute to IBD development.
The suppressive activity of CD4
+ CD25
bright regulatory T
cells from BN
m rats is defective
Immune-mediated inflammation of the gastrointestinal tract is
commonly observed when natural Treg, defined by the expression
of Foxp3 and CD25, are dysregulated or deficient [7]. We thus
wondered whether the IBD developing spontaneously by BN
m rats
was the consequence of a quantitative and/or qualitative defect in the
Treg compartment. The absolute number of Treg was indeed
reduced in the thymus, spleen and LNs from BN
m compared to BN
rats (Figure 4A). The proportion of CD4 Treg in BN
m thymus was
decreased, indicating that the mutated gene is also involved in thymic
Foxp3
+ CD4 T cell development (Figure S5A). In contrast, this
proportion was increased in spleen and mLNs (Figure S5A),
suggesting that this quantitative defect of Treg is not responsible for
IBD development. We therefore assessed the suppressive activity of
Treg in co-culture experiments, using either thymic or peripheral
CD25
bright CD4
+T cells (more than 85% being Foxp3
+). As shown in
Figure 4B, peripheral as well as thymic Treg from BN
m rats showed
almost no suppressive activity, while Treg from BN rats exerted a
potent inhibition of the proliferation of CFSE-labeled effector CD4
+
T cells. Similar results were obtained using thymidine incorporation
as a read-out of T cell proliferation (Figure S5B). Collectively, these
data indicate that the mutation carried by BN
m rats plays a crucial
role in the development and function of Foxp3
+ Treg.
To investigate the relationship between this defect in Treg and
the development of IBD, we assessed whether Treg with normal
suppressive functions could prevent the development of inflam-
matory bowel lesions in BN
m rats. To this end, we performed
Figure 1. BN
m rats exhibit a T cell autonomous lymphopenia restricted to CD4 T cells. (A) Percentage of TCRab positive cells in PBMC from
BN (n=15, black bars), BN
m (n=9, white bars) and (BN6BN
m) F1 (n=5, grey bars) rats. (B) CD4 and CD8 expression in BN and BN
m spleen T cells;
numbers indicate the cell percentages in the outlined area. (C) Absolute numbers of BN (n=4) and BNm (n=9) T cells, CD4+ and CD8+ T cells, and B
cells in spleen. Data in B and C are representative of five independent experiments. (D) CD4 and CD8 expression in BN and BN
m thymocytes; numbers
indicate cell percentages in the outlined area. (E) Absolute numbers of BN (n=5) and BN
m (n=5) in thymocyte subsets (DN: double negative; DP:
double positive; SP: simple positive). Data in D and E are representative of six independent experiments. (F) Absolute numbers of lymphocytes in
spleen of lethally irradiated (LEW6BN) F1 rats reconstituted with BN (n=6) or BN
m (n=8) T cell-depleted bone marrow cells. Data are representative
of three independent experiments. (G) Absolute numbers of donor CD4 SP and CD8 SP cells in thymus of sub-lethally irradiated (LEW6BN) F1 rats 15
days after intrathymic injection of DN thymocytes from BN (n=4) and BN
m (n=4) rats. (BN: black columns, BN
m: white columns).
doi:10.1371/journal.pgen.1002461.g001
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m rats.
We found that transfer of 4.10
6 CD25
bright CD4
+ T cells from BN
rats into 4 week-old BN
m rats significantly protected the recipients
from intestinal inflammation (Figure 4C–4D). Indeed, while the
prevalence of intestinal lesions in 12 week-old BN
m rats was 43%
(9/21), only 8% (1/11) BN
m rats transferred with CD25
bright
CD4
+ T cells from BN rats showed macroscopic lesions
(Figure 4C). Histological analyses confirmed this observation,
showing lower scores of lesions in BN
m rats transferred with BN
Treg, with a decreased cellular infiltration of the intestine wall and
the absence of granuloma (Figure 4D). This prevention was
associated with decreased amounts of TNF, IL-4, IL-13, IL-6 and
CCL2 in intestinal tissues (Figure 4E). Altogether, these results led
us to conclude that in BN
m rats, the defect in Treg suppressive
function contributes to the development of IBD.
Themis is disrupted in BN
m rats
To localize the gene responsible for CD4 T cell lymphopenia, 44
rats obtained from a (BN
m6DA)6BN
m backcross were genotyped
using 98 microsatellite markers polymorphic between the parental
strains and distributed across the genome. A genome-wide scan was
performed using R/qtl software and permutations of the pheno-
types to define genomewide LOD thresholds of 5% and 0.1%
(termed here as significant and highly significant, respectively). As
shown on Figure 5A, a highly significant quantitative trait locus
(QTL) controlling the percentage of CD4 T cells was found in a
8 cM interval of chromosome 1 (peak LOD score of 16.45;
p,0.0001). This QTL accounts for 82% of the total variance of the
trait. As shown on Figure 5B, when the 44 rats are separated
according to their genotype at the microsatellite marker nearest to
the QTL peak, D1Rat1, rats with the ‘nd’ genotype have, similarly
to their F1 parents, high CD4 T cell percentages. In contrast, rats
with the ‘nn’ genotype have low percentages, in the range of those
observed in their inbred backcross parents BN
m. The trait
distribution in the 44 rats is clearly discontinuous and falls into
two equally populated classes that are separated by the genotype at
the D1Rat1 marker. The percentage of CD4 T cells is therefore
controlled by a mutant allele at a single locus in the 8 cM QTL
region of chromosome 1. Further genotyping using 7 additional
microsatellite markers allowed the localization of the gene on
Figure 2. BN
m rats develop inflammatory bowel disease. (A) Small intestine and colon from 12 week-old BN and BN
m rats. (B, C) Length of
small intestine and colon (B) and thickness of the duodenum, jejunum, ileum and colon (C) of BN (n=10) and BN
m rats with macroscopic signs of
intestinal lesions (n=7). (D) Hematoxylin-eosin staining of duodenum, jejunum and colon from 8 to 10 week-old BN and BN
m rats. Images are
representative of microscopic lesions observed in all affected BN
m rats (original magnification: 100 X). Stars indicate granulomas; arrows point to
infiltration and double head arrows indicate the thickness of the intestinal wall. (E) CD68, CD3 and B220 immunoperoxydase staining on sections of
jejunum from 8 week-old BN
m rats. Positive staining results in a brown reaction product. HE: hematoxylin-eosin staining showing the presence of
polymorphonuclear leucocytes (original magnification: 400 X). (F) Myeloperoxidase (MPO) activity in the duodenum, jejunum, ileum and colon tissue
samples from BN (n=30) and BN
m rats with macroscopic lesions (n=21). (G) Cytokine and chemokine protein expression in duodenum from BN
(n=7) and BN
m rats with macroscopic lesions (n=7). (H) Relative mRNA expression of IL-2 and IL-17A in duodenum from BN (n=4) and BN
m rats
exhibiting intestinal macroscopic lesions (n=7). (BN: black columns, BN
m: white columns).
doi:10.1371/journal.pgen.1002461.g002
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further, 12 additional markers were used to genotype 379 rats
obtained from (BN
m6DA)6BN
m or (BN
m6DA)F2 crosses. As
shown on Figure 5C, only the genotypes at markers mapping to a
small 1.5 Mb interval of the initial region between 16.27 Mb
(D1Cel39) and 17.75 Mb (D1Cel10) were able to separate rats with
CD4 T cell lymphopenia and rats with normal CD4 counts.
According to databases RGD (Rat Genome Database: http://rgd.
mcw.edu/) and Ensembl (http://www.ensembl.org/Rattus_norve-
gicus/Info/), this region contains six genes (Figure 5C), including
Themis and Ptprk, which have both been described as involved in T
cell development [8–12]. Study of mRNA expression of these six
Figure 3. BN
m rats exhibit spontaneous T cell activation and skewed cytokine production. (A) Proportions of OX40
high, CD62L
low,
CD45RC
low and CD25
high among CD4 T cells from spleens of BN (n=4) and BN
m (n=8) rats. (B) Proliferation was assessed by [3H] Thymidine uptake in
total CD4 T cells isolated from BN (n=4) and BN
m (n=4) spleens after stimulation for 48 hours with anti-TCR mAb and increasing concentrations of
anti-CD28 mAb (left panel). Cytokine production by CD4 T cells stimulated with anti-TCR mAb and 0.2 mg/ml of anti-CD28 mAb for 48 hours (right
panels). (C) Proliferation (left panel) and cytokine production (right panels) by naive CD62L+ CD4 T cells isolated from BN (n=4) and BN
m (n=4)
spleens and stimulated as described above. Data are representative of three independent experiments. (BN: black columns, BN
m: white columns).
doi:10.1371/journal.pgen.1002461.g003
Figure 4. Impaired suppressive function of BN
m Treg is involved in the development of intestinal lesions. (A) Absolute numbers of
Foxp3+ CD4+ T cells in thymus, spleen and mLN from BN (n=7) and BN
m (n=13) rats. Data are representative of three independent experiments. (B)
Suppressive activity of thymic CD25
bright CD4+ SP cells (top panel) and peripheral CD25
bright CD4+ T cells (bottom panel) from BN or BN
m rats was
assessed in co-culture experiments with CFSE-labeled naive LEW CD4 T cells as effector cells. Proliferation was assessed by CFSE dilution (percentages
indicate the proportion of CFSE
low cells). Data are representative of three independent experiments. (C, D) Disease frequency (C) and duodenum
microscopic scores (D) in 12 week-old BN
m rats injected with PBS (white column or symbols; n=21) or with 4.10
6 BN CD25
bright CD4+ T cells (grey
columns or symbols; n=12) at 4 weeks of age. (E) Cytokine protein expression in duodenum from control BN
m rats with microscopic intestinal scores
(white columns; n=8) and from BN
m rats transferred with CD25
bright CD4+ T cells (grey columns; n=12).
doi:10.1371/journal.pgen.1002461.g004
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m rats by quantitative RT–PCR
revealed a significant decrease only for Themis mRNA expression
(Figure 5D). Sequencing of coding sequences revealed a frameshift
mutation in the Themis gene of BN
m rats, resulting from a four-
nucleotide insertion, which introduces a premature stop codon
(Figure 5E). By contrast, no polymorphism was found between the
BN and BN
m strains in the sequences coding for Ptprk (data not
shown). Consistent with these findings, western blot analysis using
Themis-specific antibodies that recognize either the N- or C-
terminal fragments of the protein revealed no detectable Themis
expression in BN
m thymocytes, whereas it was detectable at the
predictedsizeof73 kDainproteinextractsfromBNrats(Figure5F).
Together, these data strongly suggest that the CD4 T cell
lymphopenia observed in BN
m rats results from a disruption of
the Themis gene and that the BN
m rat thus represents a spontaneous
Themis knock-out rat model.
Figure 5. BN
m rats carry a disrupted Themis gene. (A) Genome scan for loci controlling the percentage of CD4 T cells in the blood of 44
(BN
m6DA)6BN
m rats. Horizontal lines represent genome-wide significance thresholds of 5% (significant) and 0.1% (highly significant) as determined
by permutation tests. (B) Percentages of CD4 T cells in 44 (BN
m6DA)6BN
m backcross rats classified according to their genotypes at the microsatellite
marker of chromosome 1 nearest to the QTL. In each group, horizontal bars represent the mean values. nn: homozygous BN (n=23); nd:
heterozygous BN-DA (n=21). (C) Fine mapping of the BN
m mutation in 28 (BN
m6DA) F2 or (BN
m6DA)6BN
m backcross rats, among which 16 showed
normal proportions of CD4 T lymphocytes (Unaffected) and 12 showed CD4 T cell lymphopenia (Affected). The position of each microsatellite marker
on chromosome 1 is indicated in megabases (Mb). White: homozygous BN
m; black: heterozygous BN
m/DA. Rec: number of rats characterized by a
given recombination. The physical map of the critical 1.5 Mb interval containing 6 genes is shown underneath. (D) Relative mRNA expression of the 6
genes in BN
m (n=4) and BN (n=4) thymocytes. Data are representative of two independent experiments. (E) Electrophoregram, nucleic acid
sequences and corresponding amino acids of the BN and BN
m Themis gene in the region surrounding the 4 nucleotide insertion corresponding to
the BN
m mutation (boxed). (F) Immunoblot analysis of Themis and b-actin in thymocytes from BN, BN
m, LEW and DA rats, C57BL/6 mice and in human
PBMC using anti-Themis antibodies specific either for the mouse C-terminal (left panel) or the human N-terminal (right panel) portion of the protein.
doi:10.1371/journal.pgen.1002461.g005
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In the present study, we serendipitously discovered a sponta-
neous mutation in the BN rat strain, which leads to lymphopenia
and increased susceptibility to inflammatory bowel disease. We
have mapped this mutation to an insertion of four nucleotides
causing the disruption of the gene encoding the Themis protein.
Themis (thymocyte-expressed molecule involved in selection), also
known as Gasp (Grb2-associating protein), has been recently
identified in mice as an essential component of the early TCR
signaling machinery [13] that plays an important role in positive
selection during thymic T cell development [8–11]. Indeed,
Themis-deficient mice have considerably fewer thymic and
peripheral CD4 and CD8 T cells, although the CD4 population
is affected more severely than CD8 population [8–11]. In our rat
model, the Themis deficiency was found to affect more specifically
the CD4 T cell compartment. In the effector T cell compartment,
the absence of Themis was associated with CD4 T cell activation,
increased production of Th17-Th2 cytokines and reduction of
IFN-c production. Concerning the Treg compartment, not only
was the proportion and absolute numbers of thymic CD4 Treg
decreased in Themis-deficient rats, but the Themis-deficient CD4
+
CD25
bright T cells also exhibited a defect in their suppressive
activity. We found that this defect contributes to the spontaneous
development of IBD in BN
m rats since their complementation with
BN Treg decreases disease incidence and severity. Finally, the
majority of diseased BN
m rats (77%) harbors autoantibodies
against intestinal tissues. Thus, our study highlights the contribu-
tion of Themis to both the immune system and intestinal
homeostasis.
BN
m rats develop an inflammatory disease that affects
preferentially the gut tissue. This might be related to the BN
genetic background, since we found that BN rats were highly
sensitive to TNBS induced colitis (our unpublished data). Of note,
no pathological manifestations have been reported in Themis-
deficient mice. Differences in species, or the particular BN genetic
background might explain this distinct susceptibility to IBD. This
raises interesting questions regarding the basis for the similarities
and differences between the roles of Themis in regulating the
immune system and the digestive tract homeostasis in mice versus
rats. Among the rodent models of T cell immunodeficiency for
which the development of an IBD has been reported, the Long-
Evans Cinnamon (LEC) rat model is of particular interest.
Similarly to BN
m rats, an arrest in the maturation of thymocytes
from CD4
+CD8
+ to CD4
+ SP was observed in LEC rats [14].
While two groups initially attributed this defect to the invalidation
of the Ptprk gene [12,15], a subsequent report suggested that, in
LEC rats, immunodeficiency results from a combined deletion of
both Ptprk and Themis genes [16]. LEC rats also develop IBD, but
the disease is different from the IBD observed in BN
m rats. Indeed,
inflammatory lesions in LEC rats are restricted to the cecum and
colon, while inflammation affects the whole intestine in BN
m rats.
Moreover, the disease in LEC rats is associated with an increased
secretion of Th1 cytokines while it is associated with a Th2/Th17
cytokine imbalance in BN
m rats. Finally, LEC rats, but not BN
m
rats, also develop Wilson’s disease. These differences between LEC
and BN
m rats can be attributed to differences in genetic
backgrounds, or more likely, to a complex interplay between
Ptprk and Themis in LEC rats. The present study clearly
establishes that Themis impacts on Treg suppressive function
independently of Ptprk and that this effect is involved in the
development of IBD lesions.
Our results document that Themis acts as a key player in the
suppressive function of Treg at an early stage of thymic
development, independently of lymphopenia and inflammation.
Indeed, the defect in Treg in BN
m rats is present in CD4 SP
thymocytes and is observed in the periphery of 6 week-old animals,
at a time when inflammatory bowel lesions have not yet
developed. The impaired function of Treg observed in BN
m rats
probably contributes to the physiopathology of IBD since
complementation of BN
m rat with wild type Treg inhibited
disease development. Finally, analysis of the expression of CTLA-
4, GITR, IL10-R, TGF-bR and Foxp3 by quantitative RT-PCR
did not reveal any differences between Treg from BN and BN
m
rats (data not shown), indicating that defective expression of these
molecules is not the cause of impaired Treg function. The impact
of Themis on T cell thymic selection, and on mature T cell
functions likely results from its role in proximal signaling
downstream of the TCR. Indeed, after TCR triggering, Themis
is phosphorylated on tyrosine residues within seconds, both in
mouse and human T cells [13]. This phosphorylation depends on
LAT, Lck and SLP-76 [13] and allows Themis to act as an
adaptor protein that binds to LAT, Grb2 and PLC-c. Consistent
with our data, mice deficient for Themis partners such as PLC-c
or LAT also develop immune-mediated diseases linked to defects
in the suppressive functions of CD4 Treg [17–19]. Moreover,
despite normal Foxp3 expression, Themis, LAT or PLC-c
deficient CD4
+ CD25
+ T cells are ineffective in controlling the
proliferation of effector T cells [17,18,20]. Together, these data
suggest that the Themis/LAT/PLC-c signaling hub is mandatory
for the suppressive functions of Foxp3
+ CD4 T cells.
In humans, the etiology of IBD is still unknown. The consensus
hypothesis is that, in genetically predisposed individuals, both
environmental factors such as the luminal content and endogenous
factors (defects in barrier, vascular or neuronal functions) trigger
an uncontrolled inflammatory response [21]. The main forms of
IBD are Crohn’s disease and ulcerative colitis, which differ mostly
by the region of the gut where inflammation progresses and the
depth of inflammatory damage. While ulcerative colitis progresses
from the rectum towards the colon, presenting only superficial
(mucosal) damage, Crohn’s disease can affect all parts of the
digestive tract and is characterized by transmural damage and
inflammatory cell infiltration [22]. Lesions observed in Themis-
deficient BN rats display several characteristics shared with
Crohn’s disease. Inflammation in BN
m rats involves the entire
intestinal tract (from the duodenum to the distal colon) and
appears patchy all along the digestive tract. Inflammatory cells
infiltrates are found in deep layers of the intestine in BN
m rats
(submucosa and muscle layers) and the granulomas are very
similar to those seen in Crohn’s disease [23,24]. In contrast to
Crohn’s disease, however, IBD in Themis-deficient rats does not
show superficial mucosa damage, diarrhea or bleeding.
To date, genome-wide association studies performed in patients
suffering from IBD [25,26] have not identified the genomic region
bearing Themis as a susceptibility locus. Such an association,
however, has been found in patients suffering from celiac disease,
another multi-factorial immune-mediated disease of the intestinal
tract [27]. Both diseases share common physiopathological
features, such as an initial increase in intestinal permeability and
the T helper pattern of the immune response [28]. Accordingly,
the two diseases can occur concomitantly in families or individual
patients and the prevalence of IBD is increased in patients
suffering from celiac disease [29,30]. Recently, a meta-analysis of
genome-wide association data from celiac disease and Crohn’s
disease has identified several risk loci shared by both diseases [31],
thus adding further support for common pathophysiological
pathways and to the possible involvement of THEMIS in human
IBD. Nowadays, it is estimated that the identified genes associated
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susceptibility genes still remain to be discovered. Gene identifica-
tion in humans is hampered by several factors including variable
penetrance, low relative risk associated to a single disease allele,
epistasis, genetic heterogeneity of human populations and
variability of environmental factors [32]. Thus, animal models of
IBD, which develop under stable and controlled laboratory
conditions, represent a very useful tool to study the pathogenesis
of IBD by identifying the genes involved and deciphering their
mechanisms of action. We propose that Themis, due to its role on
CD4 T cell functions and immune system homeostasis, should
now be considered as a candidate gene for IBD susceptibility, as
well as for other immune mediated diseases where a dysfunction of
Treg is documented or suspected. The rat model we describe will
probably help to understand how Themis directs Treg function,
which is indeed an important issue given the pivotal role of Treg in
maintaining immunological tolerance.
In conclusion, our study highlights the importance of sponta-
neous mutations in developing new animal models of human
genetic disorders, which are invaluable tools for hunting new genes
and analyzing their functions. We describe a rat model of
spontaneous IBD that shares many features with Crohn’s disease.
We found a disruption of the gene encoding Themis, which leads
to impaired regulatory T cell function, thus favoring IBD
development. While the role of Themis in thymic selection has
been previously established, our study provides the first evidence
for a role of Themis in homeostasis of the digestive tract, through
an effect on the suppressive function of natural CD4 Treg. We
thus believe that Themis dysfunction could also participate in the
pathogenesis of other diseases characterized by chronic inflam-
mation resulting from a defect in the Treg compartment.
Materials and Methods
Animals
Brown-Norway (BN), Lewis (LEW) and Dark-Agouti (DA) rats
were obtained from Janvier Laboratories (Le Genest-Saint-Isle,
France) and bred and maintained under specific pathogen–free
conditions in our facility, in accordance with European guidelines.
The mutation responsible for CD4 T cell lymphopenia arose
spontaneously in our colony of BN rats after brother and sister
mating. Lymphopenic rats were intercrossed to create the new
strain, homozygous for the recessive mutation, called BN
m. This
study was carried out in accordance with the recommendations in
the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol was approved by the
Committee on the Ethics of Animal Experiments (Licence
number: 31259).
Antibodies, flow cytometry, and isolation of leukocyte
subpopulations
Cell suspensions were prepared from thymus, spleen, mLN or
BM. The mAbs used were as follows: OX6 (anti-rat MCH class II),
OX8 (anti-rat CD8a), OX27 (anti-rat RT1-A
c,n), OX33 (anti-rat
CD45RA), OX39 (anti-rat CD25), B5 (anti-rat RT1-A
a,b,l), V65
(anti-rat TCRcd), 3.2.3 (anti-rat NKR-P1), ED1 (anti-rat CD68),
W3/25 (anti-rat CD4), R73 (anti-rat TCRab) and 341 (anti-rat
CD8b). The mAbs used for flow cytometry were either prepared in
our own laboratory or purchased from Biolegend, Abd Serotech,
BD Biosciences and eBioscience. For isolation of CD4 T cells, cell
suspensions prepared from spleen and LN were incubated with a
mixture of the following mAbs: OX6, OX33, 3.2.3, V65 and OX8
and were negatively selected using anti-mouse IgG magnetic
microbeads (Dynal, Oslo, Norway). For Treg purification,
negatively selected CD4 T cells were stained with 341-FITC
(anti-rat CD8b), R73-APC (anti-rat TCRab), W3/25-PB (anti-rat
CD4), and OX39-PE (anti-rat CD25) and electronically sorted
using a Facs Aria II-Sorp (BD Biosciences). The purity of the
sorted cells was checked and was greater than 98%.
Radiation bone marrow chimeras
(LEW6BN) F1 recipient male rats were subjected to 8.5 Gy
total body irradiation (
137Cs source) 1 day before transplantation
with bone marrow from BN or BN
m rats. Recipients were
sacrificed 16 weeks after transfer. The extent of hematopoietic cell
replacement by donor cells was analyzed using RT1-A haplotype-
specific mAbs and was consistently of at least 96%.
Intrathymic transfer of DN thymocytes
(LEW6BN) F1 recipient male rats were subjected to 2.5 Gy
total body irradiation (
137Cs source) 1 day before intrathymic DN
cell transplantation. DN cells were purified from the thymus by
negative selection using anti-CD4 (W3/25) and CD8 (OX8) mAbs
and anti-mouse IgG magnetic microbeads (Dynal, Oslo, Norway).
Recipients were killed two weeks after transfer and thymus was
analyzed for the origin of immune cells, using RT1-A haplotype-
specific mAbs.
Linkage analysis and fine mapping
For the initial genome screen, the percentage of CD4 T cells
was assessed in 44 rats obtained from a (BN
m6DA)6BN
m
backcross. These rats were genotyped for 98 polymorphic
microsatellite markers spread across the genome at 20–30 cM
intervals, as already described [33]. The R/qtl software [34] was
used for mapping loci controlling the phenotypic trait (QTLs) and
genome-wide thresholds of 5% and 0.1% significance were derived
from 10,000 permutations of shuffled phenotypes. Further
genotyping using 7 additional microsatellite markers allowed the
localization of the gene on chromosome 1 within a ,10.3 Mb
interval. Then, genetic dissection of the region harboring the
mutated gene was conducted in (BN
m6DA)6BN
m backcrosses
and (BN
m6DA) F2 hybrid rats. For this purpose, a genetic map
with a high density of markers was constructed. Among the 379
rats that were genotyped and phenotyped for CD4 lymphopenia,
28 rats showed recombination within the ,10.3 Mb and were
further genotyped using 12 additional microsatellite markers,
allowing the localization of the mutated gene within a ,1.5 Mb
interval. The sequences of the forward and reverse primers of the
new markers used for the fine mapping of the genetic defect and
designed in silico are the following:
D1Cel39: F-CCACAGTGTTTGAGTGAAAGGCCT;
R-CATGATTGCTGTGCTGTGTGTGTG;
D1Cel5: F-CAAATTAGATACAATCCACTTGGG;
R-TTCAGTAACCTGTATGAATGCTTA;
D1Cel24: F-TGCTCACGAGTCTATCTCCCAGGT;
R-GGGCAGCTCTTGAGATTCAGGTG;
D1Cel10: F-AGCACCTGCATTCACAATGACACA;
R-GCTTTTCAGCACTAGCCTTCCCTT
The physical map of the interval was extracted from the rat genome
V3.4 assembly at the rat genome database (http://rgd.mcw.edu/).
Quantification of mRNAs by RT–PCR
Total RNA was prepared using the RNeasy kit (Qiagen). cDNA
generated by SuperScript III (Invitrogen) were analyzed using
primers for the indicated genes. Real-time PCR was performed
using SYBR green. Results were normalized to Atp5b expression
levels. The primers used were as follows:
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R-GCTGCAGAGCTCCGAGTTCAT
IL-17: F-AGCCGCAATGAGGACCCT;
R-ATGTGGTGGTCCAACTTCCC
Ahi1: F-AGAGCGAGCCCATTCTTCTT;
R-CTGTAGCGCTTCAACATTTCA
Aldh8: F-GATAGCCAAGCCCAGCGA;
R-CCTGGTGGCACACCTGCT
Hbs1l: F-GAGAGCATGGCCTTTTGGTC;
R-GTTGCCAATTTACCTGGTCCA
Myb: F-CCCCAAATATTCTTACGAGCTCTG;
R-GTACGGTAAAGGCTTTGAGAACG
Ptprk: F-AGAAGCCTGCTTATGTGGAGA;
R-TCAAAATATGCAGCTTTAAATTCG
Themis:F-TTCGAGCTGCCCATGAAT;
R-TCCATTGTCAGGTATGGAGTTTT
Atp5b: F-CTATGACCATCTCCCGGAACA;
R-CAGCTTGTCAGCCTTTGCC
Western blot
Cells were harvested in lysis buffer containing a cocktail of
protease and phosphatase inhibitors (Complete Mini, EDTA-free;
Roche). Proteins were separated on 10% NuPAGE midi gels
(Invitrogen) and blotted onto nitrocellulose membranes. Mem-
branes were probed with anti-Themis rabbit polyclonal antibody
that recognizes the C-terminal portion of mouse Themis (kindly
provided by Paul E Love), or with a monoclonal antibody that
recognizes the N-terminal portion of human Themis (Sigma) and
then probed with b-actin mAb antibody (clone AC-15, Sigma),
before incubation with horseradish peroxidase-conjugated second-
ary antibodies (Amersham). Signals were revealed with Super-
Signal West Pico chemiluminescent substrate (Pierce).
Sequencing
Sequencing of Themis and Ptprk coding regions was performed
according to data available on genomic databases. Total RNA was
extracted (RNeasy minikit, Qiagen), and reverse transcribed
(SuperScript III first-strand synthesis kit, Invitrogen). Sequencing
reactions were carried out with the BigDye Terminator version 3.1
(Applied Biosystems) and recorded on ABI 3130XL. Sequences
were analyzed with Vector NTI software (InforMax).
Proliferative responses, cytokine assays, and Treg
suppression assays
For cytokine production assays, total CD4 T cells or naive
CD62L
+ CD4 T cells (10
5/well) were purified and stimulated with
plate-bound anti-TCR (R73, 1 mg/ml) and soluble anti-CD28
(JJ319, 0.01 to 0.2 mg/ml) in 96-well flat-bottom plates for
48 hours in complete RPMI (Invitrogen). Cytokine production
was examined in the cell supernatants by Luminex multiplex kit
(Millipore). For Treg suppression assays, CD4
+ CD25
bright were
sorted using a FACS Aria II-Sorp (BD Biosciences). Co-culture
experiments were performed using naive Lewis CD4 T cells (10
5/
well) stained with CFSE (Peprotech) as effector cells. These cells
were stimulated with irradiated syngeneic APC (0.5610
5/well; T
cell-depleted splenocytes) and plate-bound anti-CD3 mAb (G4.18;
0.5 mg/ml) in the presence of 0.5610
5 Treg purified from the
spleen or thymus. CFSE dilution was estimated by flow cytometry
after 60 hours of culture. Proliferation was also analyzed by [3H]
Thymidine incorporation, added during the last 18 hours of
culture.
Transfer of wild-type CD25
bright CD4
+ T cells
Four week-old BN
m rats were transferred with PBS (control) or
with 4.10
6 of FACS-sorted CD25
bright CD4
+ T cells purified from
the spleens and LN of BN rats. 8 weeks after transfer, BN
m rats
were sacrificed and intestinal inflammation was assessed as
described below. Samples of duodenum were collected to perform
microscopic analyses and dosage of cytokine concentrations.
Histology and immuno-histochemistry
Skin, liver, pancreas, lung, heart, brain, testis, thyroid, the entire
gastrointestinal tract, aorta, spleen, thymus and LN were dissected
and fixed in 4% paraformaldehyde before embedding in paraffin
and processing for conventional hematoxylin-eosin staining.
Selected panels of serial sections were processed for immuno-
histochemical labeling with anti-CD3 (polyclonal rabbit serum,
IR503, Dako), B220 (OX33 hybridoma supernatant) and CD68
(ED1 hybridoma supernatant). Two pathologists evaluated the
intestinal lesions independently using Wallace score.
Detection of autoantibodies
For the detection of autoantibodies directed against gut, liver,
lung or kidney, tissues isolated from SCID/Beige BALB/c mice
were snap frozen in liquid nitrogen and 3–5 mm sections were cut
using a cryomicrotome. Sections were fixed in acetone at 220uC
for 20 min and stored at 280uC. Sera diluted in PBS 0.1% BSA
were applied at the chosen dilution (1/200) for 60 min at room
temperature. After rinsing twice in PBS, slides were incubated for
30 min with a goat anti-rat immunoglobulin G coupled to Alexa
Fluor 488 (Jackson Immunoresearch). Slides were then washed
twice in PBS before mounting in anti-fading medium and direct
observation with immunofluorescence microscopy. The intensity
of immunofluorescent staining was blindly evaluated by O.A.
Quantification of myeloperoxidase activity and cytokine
levels in intestinal tissues
MPO activity was measured as an index of granulocyte
infiltration. Briefly, tissue samples were homogenized in a solution
of 0.5% hexadecyltrimethylammonium bromide and supernatants
were added to O-dianisidine dihydrocholoride solution supple-
mented with 1% hydrogen peroxide. Optical density readings
were taken at 450 nm. For cytokine analysis, intestinal samples
were homogenized with Precellys beads (Ozyme) in 250 mL of cell
lysis buffer (Cell Signaling Technology) containing a cocktail of
protease and phosphatase inhibitors (Complete Mini, EDTA-free;
Roche). Supernatants were assessed for cytokines by Luminex
multiplex kit (Millipore) and for protein levels using Bradford
Reagent (Bio-Rad).
Statistical analysis
Results were expressed as means 6 s.e.m. Comparisons
between groups were done by the unpaired Student’s t test using
Prism software. Fisher’s exact test was used to analyze the
prevalence and macroscopic scores in BN
m rats having received or
not normal regulatory T cell from BN rats. Results were
considered statistically significant when the p value was #0.05.
ns: not significant; *: p#0.05; **: p#0.01; ***: p#0.001.
Supporting Information
Figure S1 BN
m rats show a lymphopenia restricted to CD4 T
cells. Absolute numbers of total, CD4+ and CD8+ T cells, and B
cells in submandibular lymph nodes from BN (black columns;
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m (white columns; n=4) rats. Data are representa-
tive of four independent experiments.
(EPS)
Figure S2 BN
m rat thymic epithelium is able to support CD4 SP
cells differentiation. Irradiated BN or BN
m recipients were
reconstituted i.v. with 8.10
7 T cell-depleted bone marrow cells
originating from (LEW6BN) F1 rats. Recipients were sacrificed 16
weeks after transfer. Absolute numbers of lymphocytes in spleens
of lethally irradiated BN (black columns; n=4) and BN
m (white
columns; n=4) rats reconstituted with (LEW6BN) F1 rats T cell-
depleted bone marrow cells. Data are representative of three
independent experiments.
(EPS)
Figure S3 BN
m rats spontaneously develop features of inflam-
matory bowel disease. (A) Autoantibodies against SCID/Beige
BALB/c mouse colon, ileum, lung, kidney and liver tissues
detected after staining with sera (dilution 1/200) from BN
m (top)
and BN (bottom) rats and goat anti-rat immunoglobulin G
coupled to Alexa Fluor 488 (ml: muscular layer, LP: Lamina
propria, L: lumen, v: venule, a: arteriole, g: glomerulus). (B)
Prevalence of histological lesions of the disease in BN (black
squares) and BN
m (open circles) rats according to age. 5–7 weeks of
age: 13 BN, 21 BN
m; 8–10 weeks of age: 28 BN, 49 BN
m; 11–12
weeks of age: 25 BN, 23 BN
m; 34 weeks of age: 6 BN, 6 BN
m (C)
Duodenum, jejunum, ileum and colon microscopic scores of 8–12
week-old BN (black squares, n=55) and BN
m rats (open circles,
n=72).
(EPS)
Figure S4 BN
m rats exhibit spontaneous T cell activation and
skewed cytokine production. (A) Proportions of OX40
high,
CD62L
low, CD45RC
low and CD25
high among CD4 T cells from
mLN of BN (n=4) and BN
m (n=8) rats. (B) Proliferation was
assessed by [3H] Thymidine uptake in total CD4 T cells isolated
from BN (n=4) and BN
m (n=4) mLN and stimulated for
48 hours with anti-TCR mAb and increasing concentrations of
anti-CD28 mAb (left panel). Cytokine production by CD4 T cells
stimulated with anti-TCR mAb and 0.2 mg/ml of anti-CD28 mAb
for 48 hours (right panels). (C) Four-week-old BN
m rats were
injected with OX38, an anti-CD4 depleting mAb (300 mg per
100 g of body weight), 3 times a week (grey columns, n=10) or
PBS (white, columns n=12). The proportion of CD4 T cells in
PBMC was tested by flow cytometry three weeks after the first
anti-CD4 injection (left panel). IBD development tested 8 weeks
after the first anti-CD4 injection by analyzing the prevalence, the
length of small intestine and the macroscopic and microscopic
scores of the duodenum (right panels).
(EPS)
Figure S5 The suppressive activity of BN
m CD4
+ CD25
+ Treg is
severely impaired. (A) Percentages of Foxp3+ CD4 SP in thymus,
spleen and mLN from BN (n=7) and BN
m (n=13) rats. Data are
representative of three independent experiments. (B) Naive
purified BN CD4 T cells were stimulated with irradiated syngeneic
APC and coated anti-CD3 in presence of decreased numbers of
FACS-sorted CD4+ CD25+ Treg and cultured in 96-well round-
bottom plates for 48 hours. Proliferation was analyzed by [3H]
Thymidine incorporation during the last 18 hours. The data
represent the suppressive activity of CD25+ CD4+ T cells from
BN (black squares) and BN
m rats (open circles) in co-culture
experiments using BN naive CD4 T cells as effectors. Data are
representative of three independent experiments.
(EPS)
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